Search by Drug Name or NDC

    NDC 00004-0039-09 Valcyte 50 mg/mL Details

    Valcyte 50 mg/mL

    Valcyte is a ORAL POWDER, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Genentech, Inc.. The primary component is VALGANCICLOVIR HYDROCHLORIDE.

    Product Information

    NDC 00004-0039
    Product ID 0004-0039_489edd7b-59eb-40d9-83d5-abc96aaac2cb
    Associated GPIs 12200066102120
    GCN Sequence Number 064506
    GCN Sequence Number Description valganciclovir HCl SOLN RECON 50 MG/ML ORAL
    HIC3 W5A
    HIC3 Description ANTIVIRALS, GENERAL
    GCN 14453
    HICL Sequence Number 022033
    HICL Sequence Number Description VALGANCICLOVIR HCL
    Brand/Generic Brand
    Proprietary Name Valcyte
    Proprietary Name Suffix n/a
    Non-Proprietary Name valganciclovir hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form POWDER, FOR SOLUTION
    Route ORAL
    Active Ingredient Strength 50
    Active Ingredient Units mg/mL
    Substance Name VALGANCICLOVIR HYDROCHLORIDE
    Labeler Name Genentech, Inc.
    Pharmaceutical Class Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA022257
    Listing Certified Through 2025-12-31

    Package

    NDC 00004-0039-09 (00004003909)

    NDC Package Code 0004-0039-09
    Billing NDC 00004003909
    Package 1 BOTTLE, GLASS in 1 CARTON (0004-0039-09) / 100 mL in 1 BOTTLE, GLASS
    Marketing Start Date 2009-08-28
    NDC Exclude Flag N
    Pricing Information N/A